Skip to main content
. 2018 Dec 12;10:6869–6877. doi: 10.2147/CMAR.S186047

Table 3.

Relationship between the number of examined LNs and cancer-specific survival in univariate and multivariate analysis

Variable Number Univariate analysis
Multivariate analysis
HR (95% CI) P-value HR (95% CI) P-value

Gender 0.093
 Male 392
 Female 157 0.771 (0.569–1.045)
Age (years) <0.001 1.807 (1.382–2.363) <0.001
 ≤65 374
 >65 175 1.828 (1.399–2.387)
Smoking status 0.052
 Never 226
 Former 323 1.306 (0.996–1.711)
Tumor size (cm) 0.289
 ≤4 426
 >4 123 1.179 (0.869–1.598)
Tumor location 0.995
 Left 228
 Right 321 0.999 (0.767–1.302)
Histological type 0.349
 Squamous 174
 Adenocarcinoma 325 1.162 (0.868–1.556) 0.314
 Adenosqumaous 38 1.376 (0.808–2.343) 0.240
 Others 12 0.480 (0.117–1.962) 0.307
Visceral pleura invasion 0.584
 No 216
 Yes 333 1.078 (0.823–1.412)
Bronchia invasion 0.040 0.795 (0.570–1.109) 0.177
 No 407
 Yes 142 0.712 (0.513–0.987)
Differentiation 0.172
 Well or moderate 333
 Poor or undifferentiated 216 1.202 (0.923–1.567)
Adjuvant therapy 0.076
 No 459
 Yes 90 0.704 (0.476–1.040)
Number of examined LNs 0.045 0.854 (0.747–0.976) 0.020
 1–2 28
 3–7 109 0.761 (0.427–1.356) 0.354
 8–11 110 0.803 (0.452–1.424) 0.452
 ≥12 302 0.566 (0.330–0.972) 0.039
Number of examined N1 station 0.691
 ≥3 38
 <3 511 1.112 (0.658–1.880)
Number of examined N2 station 0.775
 ≥3 374
 <3 175 1.042 (0.786–1.380)
Total resected station 0.830
 ≥6 146
 <6 403 1.033 (0.771–1.384)

Abbreviation: LN, lymph node.